Corneal thickness recovers after CXL

Article

After a corneal collagen cross-linking (CXL) procedure a patient's cornea thins but then recovers towards original thickness.

After a corneal collagen cross-linking (CXL) procedure a patient's cornea thins but then recovers towards original thickness, according to a one-year follow-up study published in the Journals of Cataract and Refractive Surgery.

Dr Peter S. Hersh et al., Cornea and Laser Eye Institute, New Jersey, USA, studied 54 eyes with keratoconus and 28 eyes with ecstasia after LASIK. The outcome measures were corneal thickness at the apex, the thinnest point and the pupil centre. These were measured at baseline and 1, 3, 6 and 12 months post-CXL.

Mean preoperative thinnest pachymetry was 440.7 μm ± 52.9 SD. Apex and corneal thickness returned to baseline after 1 year. Corneal thickness recovered more rapidly in ecstasia patients than in keratoconus patients. Although the researchers found that the corneal thickness was reduced up to 3-months post-op, the baseline thickness was recovered at 3 to 6-months follow-up.

In conclusion, the baseline thickness of the cornea is recovered after CXL but the causes and possible effects of this change in thickness still need to be explained.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.